192 related articles for article (PubMed ID: 26216673)
1. Implications on clinical management of the small renal mass in patients 80 years of age and older based on a retrospective review of the SEER database.
Russell DH; Wachtel MS; de Riese HW; Haynes AL; de Riese WT
Int Urol Nephrol; 2015 Sep; 47(9):1503-8. PubMed ID: 26216673
[TBL] [Abstract][Full Text] [Related]
2. Compared with radical nephrectomy, nephron-sparing surgery offers a long-term survival advantage in patients between the ages of 20 and 44 years with renal cell carcinomas (≤4 cm): an analysis of the SEER database.
Daugherty M; Bratslavsky G
Urol Oncol; 2014 Jul; 32(5):549-54. PubMed ID: 24495447
[TBL] [Abstract][Full Text] [Related]
3. Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes.
Long CJ; Canter DJ; Kutikov A; Li T; Simhan J; Smaldone M; Teper E; Viterbo R; Boorjian SA; Chen DY; Greenberg RE; Uzzo RG
BJU Int; 2012 May; 109(10):1450-6. PubMed ID: 22221502
[TBL] [Abstract][Full Text] [Related]
4. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
5. Life Expectancy and Variation in Treatment for Early Stage Kidney Cancer.
Daskivich TJ; Tan HJ; Litwin MS; Hu JC
J Urol; 2016 Sep; 196(3):672-7. PubMed ID: 27012644
[TBL] [Abstract][Full Text] [Related]
6. Active Surveillance in Small Renal Masses in the Elderly: A Literature Review.
Cheung DC; Finelli A
Eur Urol Focus; 2017 Oct; 3(4-5):340-351. PubMed ID: 29175368
[TBL] [Abstract][Full Text] [Related]
7. Predictors of locally advanced and metastatic disease in patients with small renal masses.
Kates M; Korets R; Sadeghi N; Pierorazio PM; McKiernan JM
BJU Int; 2012 May; 109(10):1463-7. PubMed ID: 21933329
[TBL] [Abstract][Full Text] [Related]
8. Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time.
Bianchi M; Becker A; Hansen J; Trinh QD; Tian Z; Abdollah F; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
BJU Int; 2013 Jun; 111(8):E283-9. PubMed ID: 23714646
[TBL] [Abstract][Full Text] [Related]
9. Benign lesions after partial nephrectomy for presumed renal cell carcinoma in masses 4 cm or less: prevalence and predictors in Korean patients.
Jeon HG; Lee SR; Kim KH; Oh YT; Cho NH; Rha KH; Yang SC; Han WK
Urology; 2010 Sep; 76(3):574-9. PubMed ID: 20303148
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of tumour multifocality in renal cell carcinoma.
Siracusano S; Novara G; Antonelli A; Artibani W; Bertini R; Carini M; Carmignani G; Ciciliato S; Cunico SC; Lampropoulou N; Longo N; Martorana G; Minervini A; Mirone V; Simeone C; Simonato A; Valotto C; Zattoni F; Ficarra V;
BJU Int; 2012 Dec; 110(11 Pt B):E443-8. PubMed ID: 22502873
[TBL] [Abstract][Full Text] [Related]
11. Routine ultrasonography surveillance of native kidneys for renal cell carcinoma in kidney transplant candidates.
Klein JA; Gonzalez SA; Fischbach BV; Yango AF; Rajagopal A; Rice KM; Saim M; Barri YM; Melton LB; Klintmalm GB; Chandrakantan A
Clin Transplant; 2016 Aug; 30(8):946-53. PubMed ID: 27218882
[TBL] [Abstract][Full Text] [Related]
12. Treatment for T1a Renal Cancer Substratified by Size: "Less is More".
Moskowitz D; Chang J; Ziogas A; Anton-Culver H; Clayman RV
J Urol; 2016 Oct; 196(4):1000-7. PubMed ID: 27113965
[TBL] [Abstract][Full Text] [Related]
13. Oncological outcomes of minimally invasive partial versus minimally invasive radical nephrectomy for cT1-2/N0/M0 clear cell renal cell carcinoma: a propensity score-matched analysis.
Simone G; Tuderti G; Anceschi U; Papalia R; Ferriero M; Misuraca L; Minisola F; Mastroianni R; Costantini M; Guaglianone S; Sentinelli S; Gallucci M
World J Urol; 2017 May; 35(5):789-794. PubMed ID: 27578234
[TBL] [Abstract][Full Text] [Related]
14. Incidental renal tumours.
Patard JJ
Curr Opin Urol; 2009 Sep; 19(5):454-8. PubMed ID: 19571758
[TBL] [Abstract][Full Text] [Related]
15. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
[TBL] [Abstract][Full Text] [Related]
16. Sociodemographic disparities in the treatment of small renal masses.
Becker A; Roghmann F; Trinh QD; Hansen J; Tian Z; Shariat SF; Noldus J; Perrotte P; Graefen M; Karakiewicz PI; Sun M
BJU Int; 2013 Jun; 111(8):E274-82. PubMed ID: 23714645
[TBL] [Abstract][Full Text] [Related]
17. Treatment management of small renal masses in the 21st century: a paradigm shift.
Sun M; Abdollah F; Bianchi M; Trinh QD; Jeldres C; Thuret R; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
Ann Surg Oncol; 2012 Jul; 19(7):2380-7. PubMed ID: 22322956
[TBL] [Abstract][Full Text] [Related]
18. Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era.
Culp SH; Karam JA; Wood CG
Urol Oncol; 2014 Jul; 32(5):561-8. PubMed ID: 24709415
[TBL] [Abstract][Full Text] [Related]
19. A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
Zini L; Perrotte P; Jeldres C; Capitanio U; Duclos A; Jolivet-Tremblay M; Arjane P; Péloquin F; Pharand D; Villers A; Montorsi F; Patard JJ; Karakiewicz PI
BJU Int; 2009 Apr; 103(7):899-904; discussion 904. PubMed ID: 19154499
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of surgically treated renal cell carcinoma: a single Chinese medical center experience from 2002 to 2012.
Zhang Y; Yu H; Li H
Int Urol Nephrol; 2015 Aug; 47(8):1327-33. PubMed ID: 26163269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
